Skip to main content
. 2019 Dec 15;22(3):273–282. doi: 10.22074/cellj.2020.6582

Fig 4.

Fig 4

Quantitative analysis of some cardiac-specific genes by comparative method. The expression of each gene in the group with BMP4 and bFGF treatment but without 5-Aza and VPA pretreatment has been assumed 1 (indicated by the red line) and gene expression levels in the group with 5-Aza and VPA pre-treatment was compared to that. *; P<0.05, **; P<0.01 (Pair Wise Fixed Reallocation Randomization Test® performed by REST 2009 software). BMP4; Bone morphogenetic protein 4, bFGF; basic fibroblast growth factor, 5ˊ-Aza; 5ˊ-azacytidine, and VPA; Valproic acid.